Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
US Market
Holding PHBI?
Track your performance easily

Pharmagreen Biotech (PHBI) Financial Statements

54 Followers

Pharmagreen Biotech Financial Overview

Pharmagreen Biotech's market cap is currently ―. The company's EPS TTM is $0; its P/E ratio is -14.29; Pharmagreen Biotech is scheduled to report earnings on September 2, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 1.24K-$ 597.00$ 963.00-
Gross Profit$ 757.00-$ 208.00$ -22.00-
EBIT$ -136.36K-$ -154.71K$ -179.85K$ -20.14K
EBITDA$ -136.36K-$ -154.71K$ -179.85K-
Net Income Common Stockholders$ -144.85K-$ -162.91K$ -187.98K$ -39.37K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 743.00$ 1.25K$ 5.32K$ 7.39K$ 24.96K
Total Assets$ 112.43K$ 121.57K$ 140.31K$ 162.99K$ 211.67K
Total Debt$ 356.70K$ 372.84K$ 278.40K$ 393.25K$ 359.89K
Net Debt$ 355.96K$ 371.59K$ 273.09K$ 385.86K$ 334.93K
Total Liabilities$ 2.42M$ 2.30M$ 2.29M$ 2.15M$ 2.01M
Stockholders Equity$ -2.26M$ -2.13M$ -2.10M$ -1.94M$ -1.75M
Cash Flow-
Free Cash Flow$ -1.98K-$ 7.51K$ -34.27K$ -19.50K
Operating Cash Flow$ -1.98K-$ 7.51K$ -34.27K$ -19.50K
Investing Cash Flow-----
Financing Cash Flow--$ 17.69K$ 18.84K$ 47.43K
Currency in USD

Pharmagreen Biotech Earnings and Revenue History

Pharmagreen Biotech Debt to Assets

Pharmagreen Biotech Cash Flow

Pharmagreen Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis